TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD Shareholders Equity (Quarterly) : 27.13M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.13M |
| March 31, 2026 | 26.97M |
| December 31, 2025 | 26.88M |
| September 30, 2025 | 27.44M |
| June 30, 2025 | 27.29M |
| March 31, 2025 | 26.74M |
| December 31, 2024 | 27.37M |
| September 30, 2024 | 27.09M |
| June 30, 2024 | 27.67M |
| March 31, 2024 | 28.66M |
| December 31, 2023 | 29.29M |
| September 30, 2023 | 28.05M |
| June 30, 2023 | 31.20M |
| March 31, 2023 | 32.02M |
| December 31, 2022 | |
| September 30, 2022 | -48.27M |
| June 30, 2022 | -26.07M |
| March 31, 2022 | -140.58M |
| December 31, 2021 | -93.62M |
| September 30, 2021 | -57.36M |
| June 30, 2021 | -49.07M |
| March 31, 2021 | -9.478M |
| December 31, 2020 | -124.00M |
| September 30, 2020 | -116.03M |
| June 30, 2020 | -94.09M |
| Date | Value |
|---|---|
| March 31, 2020 | -45.21M |
| December 31, 2019 | 9.201M |
| September 30, 2019 | -21.23M |
| June 30, 2019 | 8.094M |
| March 31, 2019 | 60.69M |
| December 31, 2018 | 97.52M |
| September 30, 2018 | 134.22M |
| June 30, 2018 | 77.55M |
| March 31, 2018 | 107.30M |
| December 31, 2017 | 129.91M |
| September 30, 2017 | 149.48M |
| June 30, 2017 | 93.59M |
| March 31, 2017 | 110.33M |
| December 31, 2016 | 127.49M |
| September 30, 2016 | 146.35M |
| June 30, 2016 | 167.25M |
| March 31, 2016 | 183.37M |
| December 31, 2015 | 63.06M |
| September 30, 2015 | 77.56M |
| June 30, 2015 | 63.01M |
| March 31, 2015 | 87.72M |
| December 31, 2014 | 48.39M |
| September 30, 2014 | 63.60M |
| June 30, 2014 | 37.48M |
| March 31, 2014 | 46.75M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.53M |
| Total Liabilities (Quarterly) | 10.40M |
| Debt to Equity Ratio | 0.2049 |
| Current Ratio | 2.756 |
| Net Debt Paydown Yield | 1.10% |